Group A streptococcal bacteremia: Outcome and prognostic factors

Revista Espanola de Quimioterapia

Volumn 19, Issue 4, 2006, Pages 367-375

  Vallalta Morales, Manuel ^a,c   Soriano Navarro, C J ^b   Salavert Lleti M ^a   Montero Alonso, M ^a   Perez Belles C ^a   Lopez Aldeguer J ^a   Otero, M C ^a   Gobernado Serrano, M ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^c NONE   (Spain)

Author keywords

Bacteremia; Blood cultures; Group A streptococcus; Mortality; Streptococcal shock toxic syndrome

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAM ANTIBIOTIC; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; MACROLIDE; METRONIDAZOLE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC TEST; DISEASE SEVERITY; DRUG DEPENDENCE; FEMALE; HOSPITAL INFECTION; HUMAN; IMMUNE DEFICIENCY; INCIDENCE; INFANT; INFECTION RISK; MALE; MICROBIOLOGICAL EXAMINATION; MORTALITY; NEWBORN; OUTCOME ASSESSMENT; PERIPHERAL VASCULAR DISEASE; PROGNOSIS; SKIN INFECTION; SOFT TISSUE INFECTION; STREPTOCOCCUS GROUP A; TOXIC SHOCK SYNDROME; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; COMORBIDITY; CROSS INFECTION; DIABETES COMPLICATIONS; DISEASE SUSCEPTIBILITY; DRUG RESISTANCE; FEMALE; HOSPITAL MORTALITY; HOSPITALS, UNIVERSITY; HUMANS; IMMUNOCOMPROMISED HOST; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PROGNOSIS; RETROSPECTIVE STUDIES; SHOCK, SEPTIC; SPAIN; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; SUBSTANCE ABUSE, INTRAVENOUS; TREATMENT OUTCOME; WOUND INFECTION;

EID: 33846891114     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Stevens, D.L. Invasive group A streptococcus infections. Clin Infect Dis 1992; 14: 2-13.
2. Bisno, A.L., Stevens, D.L. Streptococcus pyogenes. In: Mandell, G.L., Douglas, G., Bennet, J.E. (Eds). Principles and Practice of Infectious Diseases. Buenos Aires: Ed. Médica Panamericana 2002, 2550-2568.
3. Torrabadella, P., Pedro-Botet, M.L., Xirgu, J., Armengol, S., Catalán, R. Invasive infections caused by Streptococcus pyogenes. Changes in their clinical characteristics, new physiopathologic aspects, and current therapeutic approach. Enferm Infecc Microbiol Clin 1994; 12: 505-510.
4. Committee on Infectious Diseases. Severe invasive group A streptococcal infections: A subject review. Pediatrics 1998; 101: 136-140.
5. Stevens, D.L., Tanner, M.H., Winship, J. et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989; 321: 1-7.
6. Hoge, C.W., Schwartz, B., Talkington, D.F., Breiman, R.F., MacNeill, E.M., Englender, S.J. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study. JAMA 1993; 269: 384-389.
7. Breathnach, A.S., Eykyn, S.J. Streptococcus pyogenes bacteraemia: A 27-year study in a London teaching hospital. Scand J Infect Dis 1997; 29: 473-478.
8. Stromberg, A., Romanus, V., Burman, L.G. Outbreak of group A streptococcal bacteremia in Sweden: An epidemiologic and clinical study. J Infect Dis 1991; 164: 595-598.
9. Andersen, M.M., Ronne, T. Group A streptococcal bacteraemias in Denmark 1987-1989. J Infect 1995; 31: 33-37.
10. Lentnek, A.L., Giger, O., O'Rourke, E. Group A beta-hemolytic streptococcus bacteremia and intravenous substance abuse. A growing clinical problem? Arch Intern Med 1990; 150: 89-93.
11. Moses, A.E., Ziv, A., Harari, M., Rahav, G., Shapiro, M., Englehard, D. Increased incidence and severity of Streptococcus pyogenes bacteremia in young children. Pediatr Infect Dis J 1995; 14: 767-770.
12. Carapetis, J., Robins-Browne, R., Martin, D., Shelby-James, T., Hogg, G. Increasing severity of invasive streptococcal disease in Australia: Clinical and molecular epidemiological features and identification of a new virulent M-nontypeable clone. Clin Infect Dis 1995; 21: 1220-1227.
13. López Bernaldo de Quirós, J.C. Streptococcus group A: New faces of an old know. Enferm Infecc Microbiol Clin 1995; 13: 273-277.
14. American College of Chest Physichians/Society of Critical Care Medicine. Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-874.
15. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections. JAMA 1993; 269: 390-391.
16. Vallalta, M., Salavert, M., Artero, A., Mahiques, L., Solaz, E., Pérez-Bellés, C. Streptococcal toxic shock syndrome: Ten years experience at a tertiary hospital. Enferm Infecc Microbiol Clin 2005; 23: 540-544.
17. Holm, S.E. Invasive group A streptococcal infections. N Engl J Med 1996; 335: 590-591.
18. Ramos, J.M., Fernández-Roblas, R., Núñez, A., Fernández-Guerrero, M.L., Soriano, F. Bacteremia caused by group A and B beta-hemolytic Streptococcus in adults. Rev Clin Esp 1995; 195: 541-545.
19. López Bernaldo de Quirós, J.C., Rodríguez- Créixems, M., Cosin, J., Cercenado, E., Wilhelmi, I., Bouza, E. Group A beta-hemolytic Streptococcus bacteremia. Med Clin (Barc) 1987; 88: 9-12.
20. López Bernaldo de Quirós, J.C., Moreno, S., Cercenado, E. et al. Group A streptococcal bacteremia. A 10-year prospective study. Medicine (Baltimore) 1997; 76: 238-248.
21. Davies, H.D., McGeer, A., Schwartz, B. et al. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med 1996; 335: 547-554.
22. Francis, J., Warren, R.E. Streptococcus pyogenes bacteraemia in Cambridge - A review of 67 episodes. Q J Med 1988; 68: 603-613.
23. Bouza, E. Invasive infections caused by group-A beta-hemolytic Streptococcus. Rev Clin Esp 1994; 194: 63-67.
24. Moses, A.E., Mevorach, D., Rahav, G., Sacks, T., Simhon, A., Shapiro, M. Group A streptococcus bacteremia at the Hadassah Medical Center in Jerusalem. Clin Infect Dis 1995; 20:1393-1395.
25. Navarro, V.J., Axelrod, P.I., Pinover, W., Hockfield, H.S., Kostman, J.R. A comparison of Streptococcus pyogenes (group A streptococcal) bacteremia at an urban and a suburban hospital. The importance of intravenous drug use. Arch Intern Med 1993; 153: 2679-2684.
26. Burkert, T., Watanakunakorn, C. Group A streptococcal bacteremia in a community teaching hospital 1980-1989. Clin Infect Dis 1992; 14: 29-37.
27. Daneman, N., McGeer, A., Low, D.E. et al. Hospital-acquired invasive group A streptococcal infections in Ontario, Canada, 1992-2000. Clin Infect Dis 2005; 41: 334-342.
28. Al Mazrou, A.M. Group A streptococcal bacteraemia: Experience at a university hospital in Riyadh. J Infect 1997; 34: 95-100.
29. Begovac, J., Kuzmanovic, N., Bejuk, D. Comparison of clinical characteristics of group A streptococcal bacteremia in children and adults. Clin Infect Dis 1996; 23: 97-100.
30. Tyrrell, G.J., Lougren, M., Kress, B., Grimsrud, K. Varicella associated invasive group A streptococcal disease in Alberta, Canada 2000-2002. Clin Infect Dis 2005; 40:1055-1057.
31. Ben-Abraham, R., Keller, N., Vered, R., Harel, R., Barzilay, Z., Paret, G. Invasive group A streptococcal infections in a large tertiary center: Epidemiology, characteristics and outcome. Infection 2002; 30: 81-85.
32. Svensson, N., Oberg, S., Henriques, B. et al. Invasive group A streptococcal infections in Sweden in 1994 and 1995: Epidemiology and clinical spectrum. Scand J Infect Dis 2000; 32: 609-614.
33. Livni, G., Ashkenazi, S., Leibovici, L. et al. Incidence and severity of group A streptococcal bacteremia in a medical center in Israel, 1981-1994. Scand J Infect Dis 1996; 28: 139-142.
34. Alós, J.I., González-Palacios, R., Cuadros, J.A., Escobar, J.C. Antibiotic sensitivity of strains of group A beta-hemolytic streptococci isolated recently. Med Clin (Barc) 1990; 94: 12-14.
35. Pérez-Trallero, E., Fernández-Mazarrasa, C., García-Rey, C. et al. Antimicrobial susceptibility of 1,685 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationship: Results of a 1-year (1998-1999) multicenter surveillance study in Spain. Antimicrob Agents and Chemother 2001; 45: 3334-3340.
36. Rodríguez-Zurita, M.E., Solís del Baño, S., Robres, P. et al. Susceptibility of Streptococcus pyogenes to macrolides and quinolones in Guadalajara, Spain. Rev Esp Quimioter 2003; 16: 61-64.
37. Reinert, R.R., Lutticken, R., Al-Lahham, A. High-level fluoroquinolone resistance in a clinical Streptoccoccus pyogenes isolate in Germany. Clin Microbiol Infect 2004; 10: 659-662.
38. Norrby-Teglund, A., Ragnar Norrby, S., Low, D.E. The treatment of severe group A streptococcal infections. Curr Infect Dis Rep 2003; 5: 28-37.
39. Nielsen, H.U., Kolmos, H.J., Frimodt-Moller, N. Beta-hemolytic streptococcal bacteremia: A review of 241 cases. Scand J Infect Dis 2002; 34: 483-486.
40. Bosch, T., Riera, M., Galmés, M., Ramírez, A., Albertí, S. Invasive infections caused by Group A streptococci: Clinical characteristics and microbiological analyses in 31 cases. Enferm Infecc Microbiol Clin 2001; 19: 371-375.
41. Megged, O., Yinnon, A.M., Raveh, D., Rudensky, B., Schlesinger, Y. Group A streptococcus bacteraemia: Comparison of adults and children in a single medical center. Clin Microbiol Infect 2006; 12: 156-162.